Champions Oncology (CSBR) Change in Cash (2010 - 2026)
Champions Oncology's (CSBR) quarterly Change in Cash came in at -$514000.0 in Q3 2026, down 195.19% year-over-year from $540000.0 in Q3 2025, and up 77.21% on a QoQ basis from -$2.3 million in Q2 2026.
Powered by 
Analysis
Champions Oncology (CSBR) Change in Cash (2010 - 2026) Analysis & Trends
Champions Oncology (CSBR) has 17 years of Change in Cash data on file, last reported at -$514000.0 in Q3 2026.
- On a quarterly basis, Change in Cash fell 195.19% year-over-year to -$514000.0 in Q3 2026; TTM through Jul 2026 was -$6.0 million, a 180.28% decrease from a year earlier, with the FY2026 full-year figure at -$4.9 million, down 168.55% from the prior year.
- Change in Cash for Q3 2026 stood at -$514000.0, up from -$2.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $6.6 million in Q2 2025 and bottomed at -$5.2 million in Q3 2023.
- Historically, Change in Cash has averaged -$22263.2 across 5 years, with a median of -$138000.0 in 2024.
- The largest YoY upside for Change in Cash was 455.84% in 2025 against a maximum downside of 1210.87% in 2025.
- Year by year, Change in Cash stood at $2.8 million in 2022, then plunged by 76.73% to $644000.0 in 2023, then plunged by 121.43% to -$138000.0 in 2024, then sank by 1210.87% to -$1.8 million in 2025, then jumped by 71.59% to -$514000.0 in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$514000.0 in Q3 2026, -$2.3 million in Q2 2026, and -$1.4 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -38.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -149.99 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 928.39 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 42.38 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 21.10 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -16.65 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -514,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.71 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -514,000.00 |
| Apr 30, 2026 | -2.26 Mn |
| Jan 31, 2026 | -1.39 Mn |
| Oct 31, 2025 | -1.81 Mn |
| Jul 31, 2025 | 540,000.00 |
| Apr 30, 2025 | 6.58 Mn |
| Jan 31, 2025 | 448,000.00 |
| Oct 31, 2024 | -138,000.00 |
| Jul 31, 2024 | 274,000.00 |
| Apr 30, 2024 | -1.85 Mn |
| Jan 31, 2024 | -1.05 Mn |
| Oct 31, 2023 | 644,000.00 |
| Jul 31, 2023 | -5.25 Mn |
| Apr 30, 2023 | -1.53 Mn |
| Jan 31, 2023 | 819,000.00 |
| Oct 31, 2022 | 2.77 Mn |
| Jul 31, 2022 | -949,000.00 |
| Apr 30, 2022 | 306,000.00 |
| Jan 31, 2022 | 3.92 Mn |
| Oct 31, 2021 | 783,000.00 |